(RTTNews) - Aprea Therapeutics, Inc. (APRE), a clinical-stage precision medicine oncology company, on Wednesday announced the closing of its previously announced oversubscribed $30 million private placement financing on March 31, 2026.
2 views
Aprea Therapeutics Closes Oversubscribed $30 Mln Private Placement; Stock Down
(RTTNews) - Aprea Therapeutics, Inc. (APRE), a clinical-stage precision medicine oncology company, on Wednesday announced the closing of its previously announced oversubscribed $30 million private placement financing…
